Aveanna Healthcare Holdings Inc.
AVAH · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 1.79B | 553.23M | -642.28M | -662.03M | -3.57 |
| 2023 FY | 1.90B | 595.43M | 8.07M | -134.52M | -0.71 |
| 2024 FY | 2.02B | 635.54M | 139.79M | -10.93M | -0.06 |
| 2025 FY | 2.43B | 805.15M | 265.38M | 225.03M | 1.10 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 1.71B | 1.72B | 19.22M | 1.36B | -4.18M |
| 2023 FY | 1.61B | 1.74B | 43.94M | 1.50B | -127.44M |
| 2024 FY | 1.66B | 1.79B | 84.29M | 1.50B | -122.09M |
| 2025 FY | 2.03B | 1.83B | 193.26M | 1.51B | 194.46M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -48.40M | -12.01M | -60.42M | — | -11.27M |
| 2023 FY | 22.67M | -6.12M | 16.56M | — | 24.73M |
| 2024 FY | 32.64M | -6.32M | 26.32M | — | 40.35M |
| 2025 FY | 122.24M | -7.45M | 114.79M | — | 108.97M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 144.73M | 1.48B | — | — | — |
| 2024 FY | 898.88M | 2.32B | — | — | — |
| 2025 FY | 1.64B | 2.97B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 589.55M | 210.80M | 80.03M | 27.03M | 0.13 |
| 2025 Q3 | 621.94M | 200.23M | 56.27M | 14.06M | 0.07 |
| 2025 Q4 | 662.48M | 210.57M | 77.27M | 178.75M | 0.88 |
| 2026 Q1 | 647.92M | 202.38M | 75.94M | 41.65M | 0.19 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 1.77B | 1.78B | 100.74M | 1.49B | -11.26M |
| 2025 Q3 | 1.81B | 1.80B | 145.87M | 1.35B | 9.91M |
| 2025 Q4 | 2.03B | 1.83B | 193.26M | 1.51B | 194.46M |
| 2026 Q1 | 2.02B | 1.78B | 189.27M | 1.50B | 240.05M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 51.57M | -1.13M | 50.44M | — | 29.24M |
| 2025 Q3 | 33.20M | -2.02M | 31.18M | — | 45.13M |
| 2025 Q4 | 49.72M | 5.50M | 55.22M | — | 47.39M |
| 2026 Q1 | 4.35M | -4.56M | -208.00K | — | -3.99M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 1.01B | 2.40B | — | — | — |
| 2025 Q3 | 1.83B | 3.03B | — | — | — |
| 2025 Q4 | 1.64B | 2.97B | — | — | — |
| 2026 Q1 | 1.37B | 2.68B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |